Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion type Assertion NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_head.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion description "[Overall, host SNPs affecting doxorubicin pharmacodynamics (CYBA rs4673) and alkylator detoxification (GSTA1 rs3957357) may predict outcome in R-CHOP21-treated DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion evidence source_evidence_literature NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion SIO_000772 19448608 NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion wasDerivedFrom befree-20150227 NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.
- NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_assertion wasGeneratedBy ECO_0000203 NP437167.RAPk5EXIiZGjALZZ7lelV3IlK4AC5keY4g8Vww2W286o0130_provenance.